Clinicopathological analysis of 598 malignant lymphomas in Taiwan: Seven-year experience in a single institution

American Journal of Hematology

Volumn 81, Issue 8, 2006, Pages 568-575

  Lee, Wing Yuan ^a,b   Tan, Tran Der ^a   Feng, An Chen ^a   Liu, Mei Ching ^a  

^a KOO FOUNDATION SUN YAT SEN CANCER CENTER   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Malignant lymphoma; Prognosis; Taiwan; WHO classification

Indexed keywords

ADULT; ARTICLE; B CELL LYMPHOMA; FEMALE; FOLLICULAR LYMPHOMA; GEOGRAPHY; HODGKIN DISEASE; HUMAN; IMMUNOPHENOTYPING; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NODULAR SCLEROSIS HODGKIN LYMPHOMA; ONSET AGE; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; T CELL LYMPHOMA; TAIWAN;

ADULT; AGE DISTRIBUTION; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; INCIDENCE; KILLER CELLS, NATURAL; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; NEOPLASM STAGING; SEX DISTRIBUTION; SURVIVAL RATE; TAIWAN; WORLD HEALTH ORGANIZATION;

EID: 33746002935     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20649     Document Type: Article

References (29)

1. Jaffe ES. Hematopathology: integration of morphologic features and biological markers for diagnosis. Mod Pathol 1999;12:109-115.
2. Jaffe ES, Harris NL, Stein H. et al. Tumours of hematopoietic and lymphoid tissues. LARC Press: Lyon; 2001.
3. Durie BG. Staging and kinetics of multiple myeloma. Semin Oncol 1985;13:300-309.
4. Chuang SS, Lin CN, Li CY. Malignant lymphoma in southern Taiwan according to the revised European-American classification of lymphoid neoplasms. Cancer 2000;89:1586-1192.
5. Chang KC, Huang GC, Jones D, et al. Distribution and prognosis of WHO lymphoma subtypes in Taiwan reveals a low incidence of germinal-center derived tumors. Leukemia Lymphoma 2004;45:1375-1384.
6. Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic location. Ann Oncol 1998;9:717-720.
7. Ko YH, Kim CW, Park CS, et al. REAL classification of malignant lymphomas in Republic of Korea. Cancer 1998;83: 806-812.
8. Shih LY, Liang DC. Non-Hodgkin's lymphoma is Asia. Hematol Oncol Clin North Am 1991;5:983-1001.
9. Velders GA, Kluin-Nelemans JC, De Boer CJ, et al. Mantle cell lymphoma: a population-based clinical study. J Clin Oncol 1996;14:129-1274.
10. The non-Hodgkin's lymphoma classification project: a clinical evaluation of the international lymphoma study groups classification of non-Hodgkin's lymphoma. Blood 1997;89:3909-3918.
11. Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 2003; 78:21-33.
12. Anderson KC, Shaughnessy JD, Barlogie B, et al. Multiple myeloma. Hematology 2002;214-240.
13. Lee SS, Cho KJ, Kim CW, et al. Clinicopathological analysis of 501 non-Hodgkin's lymphomas in Korea according to the Revised European-American Classification of lymphoid neoplasms. Histopathology 1999;35:345-354.
14. Lymphoma study group of Japanese pathologists. The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Pathol Int 2000;50:696-702.
15. Sukpanichnant S, Sonakul D, Piankijagum A, et al. Malignant lymphoma in Thailand: changes in the frequency of malignant lymphoma determined from a histopathologic and immunophenotypic analysis of 425 cases at Siriraj hospital. Cancer 1998;83:1197-1204.
16. Jaffe ES, Chan JKC, Su IJ, et al. Report on the work shop on nasal and related extranodal angiocentric T/natural killer lymphomas. Am J Surg Pathol 1996;20:103-111.
17. Isobe K, Tamaru J, Harigaya K, et al. Clinicopathological evaluation of the Revised European-American Classification of lymphoid neoplasms in Japan. Leukemia Lymphoma 1999;34: 143-149.
18. Melnyk A, Ridriguez A, Pugh WC, et al. Evaluation of the revised European-American lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma. Blood 1997;98:4514-4520.
19. John P Greer, Marsha C Kennedy, Thomas P Loughran Jr. T cell and NK cell lymphoproliferative disorders. Hematology 2001: 259-280.
20. Gisselbrecht C, Gaulard P, Lepage E, et al. Prognostic significance of T cell phenotype in aggressive non-Hodgkin's lymphoma. Blood 1998;2:76-82.
21. Edward R. Arrowsmith, William R. Macon, Marsha C Kinney, et al. Peripheral T cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European-American lymphoma classification. Leukemia Lymphoma 2003; 44:241-249.
22. Hsiao CH, Kao HL, Lin MC, et al. Ulcerative colon T cell lymphoma: an unusual entity mimicking Crohn's disease and may be associated with fulminant hemophagocytosis. Hepatogastroenterology 2002;49:950-954.
23. Chott A, Dragosics B, Radaszkiewicz T. Peripheral T cell lymphomas of the intestine. Am J Pathol 1992;141:1361-1371.
24. Murray A, Cuevas EC, Jones DB, et al. Study of the immunohistochemistry and T cell clonality of enteropathy-associated T cell lymphoma. Am J Pathol 1995;146:509-519.
25. Gale J, Simmonds PD, Mead GM, et al. Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center. J Clin Oncol 2000;18:795-803.
26. Sally LG, Joe LH. Hodgkin lymphoma in Asians: incidence patterns and risk factors in population-based data. Leukemia Res 2002;26:261-269.
27. Paulino AF, Paulino-Cabrera E, Weiss LM, et al. Hodgkin's disease in the Philippines. Mod Pathol 1996;9:115-119.
28. Liang R, Choi P, Todd D, et al. Hodgkin's disease in Hong Kong Chinese. Hematol Oncol 1998;7:395-403.
29. Kennedy BJ, Fremgen AM, Menck HR. The national cancer database report on Hodgkin's disease for 1985-1989 and 1990-1994. Cancer 1998;83:1041-1047.